Publication | Open Access

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Pancreatic CancerGastrointestinal OncologyMedicineClinical TrialsDouble-blind Phase IiiPharmacotherapyBaypan StudyAdvanced Pancreatic CancerCancer TreatmentOncologyRadiation OncologyHealth Sciences